Anna Ericsson
58Patents
16h-index
107Co-inventors
87Inventor score
Filing activity: Apr 24, 1998 → Nov 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8008481B2 | Indazole compounds | Chemistry; Metallurgy | 107 | Active |
| US7297709B2 | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors | Chemistry; Metallurgy | 68 | Expired |
| US8785639B2 | Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof | Chemistry; Metallurgy | 57 | Active |
| US8962629B2 | Tricyclic compounds | Chemistry; Metallurgy | 54 | Active |
| US9365579B2 | Tricyclic compounds | Chemistry; Metallurgy | 49 | Active |
| US9771349B2 | Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 26 | Active |
| US9624216B2 | Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9624175B2 | Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 25 | Active |
| US10005734B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 25 | Active |
| US9815817B2 | Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 24 | Active |
| US9834539B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 24 | Active |
| US9902728B2 | Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US10253015B2 | Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 19 | Active |
| US10266495B2 | Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 19 | Active |
| US10280150B2 | Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 19 | Active |
| US6462036B1 | Tricyclic pyrazole derivatives | Chemistry; Metallurgy | 18 | Expired |
| US10414752B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 16 | Active |
| US7091227B2 | Benzothiazole derivatives | Chemistry; Metallurgy | 16 | Expired |
| US10550098B2 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Human Necessities | 15 | Active |
| US10377760B2 | Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors | Emerging Cross-Sectional Technologies | 15 | Active |
| US8063091B2 | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors | Chemistry; Metallurgy | 13 | Active |
| US10675274B2 | Activating pyruvate kinase R | Chemistry; Metallurgy | 11 | Active |
| US10294206B2 | Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US11071725B2 | Activating pyruvate kinase R | Chemistry; Metallurgy | 6 | Active |
| US11014927B2 | Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.